Doxorubicin 13CD3 TFA - Request Quote
Doxorubicin 13CD3 TFA
| SZ CAT No: | SZ-D051D01 |
| CAS No | NA |
| Mol.F. | C2613CH26D3NO11 : C2HF3O2 |
| Mol.Wt. | 547.5 : 114.0 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1224610-76-7 (Unlabeled) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Doxorubicin 13CD3 TFA is chemically (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate. Doxorubicin 13CD3 TFA is supplied with detailed characterization data compliant with regulatory guideline. Doxorubicin 13CD3 TFA can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxorubicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Doxorubicin 13CD3 TFA
Purchase Doxorubicin 13CD3 TFA
Doxorubicin 13CD3 TFA suppliers
Doxorubicin 13CD3 TFA manufacturers
Doxorubicin 13CD3 TFA price
Order Doxorubicin 13CD3 TFA
Enquire Doxorubicin 13CD3 TFA
Doxorubicin 13CD3 TFA cost
Doxorubicin 13CD3 TFA Supplier
Doxorubicin 13CD3 TFA Distributor
Doxorubicin 13CD3 TFA for Method Validation
Doxorubicin Reference Standard
Doxorubicin 13CD3 TFA for ANDA Filing
Doxorubicin 13CD3 TFA for Forced Degradation Studies
Doxorubicin 13CD3 TFA Identification Standards
Doxorubicin 13CD3 TFA for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


